comparemela.com

Latest Breaking News On - Dark forest capital management - Page 1 : comparemela.com

Deciphera Pharmaceuticals (NASDAQ:DCPH) Sets New 12-Month High at $25.59

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The company traded as high as $25.59 and last traded at $25.58, with a volume of 366347 shares changing hands. The stock had previously closed at $25.57. Analysts Set New Price Targets A number of […]

United-states
Charles-schwab-investment-management-inc
Deciphera-pharmaceuticals-price-performance
Institutional-trading-of-deciphera-pharmaceuticals
Deciphera-pharmaceuticals
Deciphera-pharmaceuticals-inc
Principal-financial-group-inc
Jefferies-financial-group
Deciphera-pharmaceuticals-company-profile
Deutsche-bank
Jpmorgan-chase-co

Garner Asset Management Corp Acquires 38 Shares of Seaboard Co. (NYSEAMERICAN:SEB)

Garner Asset Management Corp grew its holdings in Seaboard Co. (NYSEAMERICAN:SEB – Free Report) by 13.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 320 shares of the company’s stock after purchasing an additional 38 shares during the period. Garner Asset […]

Turkey
Zurcher-kantonalbank-zurich-cantonalbank
Securities-exchange-commission
Seaboard-corporation
Garner-asset-management-corp
Janiczek-wealth-management
Tower-research-capital
Seaboard-co
Free-report
Asset-management-corp
Wealth-management
Research-capital

1,742,071 Shares in Udemy, Inc. (NASDAQ:UDMY) Purchased by Sea Cliff Partners Management LP

Sea Cliff Partners Management LP bought a new position in Udemy, Inc. (NASDAQ:UDMY – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 1,742,071 shares of the company’s stock, valued at approximately $25,661,000. Udemy comprises 10.0% of Sea Cliff Partners Management […]

Sea-cliff
New-york
United-states
Switzerland
Swiss
Venu-venugopal
Sarah-blanchard
Piper-sandler
Morgan-stanley
Jump-financial
Nasdaq
Cantor-fitzgerald

Bain Capital Investors LLC Has $2.78 Billion Stock Holdings in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)

Bain Capital Investors LLC lifted its position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 9.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 65,679,781 shares of the biotechnology company’s stock after purchasing an additional 5,480,052 shares during the quarter. […]

United-states
N-anthony-coles
Cerevel-therapeutics-holdings-inc
Fund-management-co
E-fund-management-co
Cerevel-therapeutics-company-profile
Nasdaq
Pacific-capital-wealth-advisors-inc
Financial-services-group-inc
Bain-capital-investors
Cerevel-therapeutics-holdings
Free-report

Peter Presunka Sells 7,583 Shares of Matterport, Inc. (NASDAQ:MTTR) Stock

Matterport, Inc. (NASDAQ:MTTR – Get Free Report) CAO Peter Presunka sold 7,583 shares of the business’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $4.41, for a total transaction of $33,441.03. Following the completion of the sale, the chief accounting officer now directly owns 92,755 shares […]

United-states
Chicago
Illinois
Peter-presunka
Piper-sandler
Matterport-inc
Matterport-company-profile
Matterport-capture-services
Capital-partners
Nasdaq
Investment-partners-management
Vanguard-group-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.